Laurus Labs Limited
LAURUSLABS.BO
Price:
$1025.95
Market Cap:
$553.95B
Laurus Labs Limited, together with its subsidiaries, engages in the development, manufacture, and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company develops, manufactures, and sells APIs and advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C therapeutic areas. It also develops and manufactures oral solid formulations for ARVs, anti-diabetic, cardiovascular, PPIs, and central nervous system. In addition, the company provides contract development and manufacturing services for pharmaceutical companies; and manufactures and sells specialt...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2016-12-19
Stock Exchange
BSE
Ticker
LAURUSLABS.BO
PE Ratio
[81.30]
ROE
[15.18%]
Current Ratio
[1.32]
Dividend Yield
[0.16%]
Enterprise Value
[575.43B]
Dividend History
The ROE as of December 2025 (TTM) for Laurus Labs Limited (LAURUSLABS.BO) is 15.18%
According to Laurus Labs Limited’s latest financial reports and current stock price. The company's current ROE is 15.18%. This represents a change of 303.38% compared to the average of 3.76% of the last 4 quarters.
Laurus Labs Limited (LAURUSLABS.BO) Historical ROE (quarterly & annually)
How has LAURUSLABS.BO ROE performed in the past?
The mean historical ROE of Laurus Labs Limited over the last ten years is 15.58%. The current 15.18% ROE has changed -2.57% with respect to the historical average. Over the past ten years (40 quarters), LAURUSLABS.BO's ROE was at its highest in in the December 2020 quarter at 12.47%. The ROE was at its lowest in in the January 2016 quarter at 0%.
Average
15.58%
Median
14.36%
Minimum
3.91%
Maximum
37.87%
Laurus Labs Limited (LAURUSLABS.BO) ROE by Quarter and Year
Discovering the peaks and valleys of Laurus Labs Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 162.52%
Maximum Annual ROE = 37.87%
Minimum Annual Increase = -80.04%
Minimum Annual ROE = 3.91%
| Year | ROE | Change |
|---|---|---|
| 2025 | 8.01% | 105.14% |
| 2024 | 3.91% | -80.04% |
| 2023 | 19.57% | -20.75% |
| 2022 | 24.69% | -34.79% |
| 2021 | 37.87% | 162.52% |
| 2020 | 14.42% | 139.73% |
| 2019 | 6.02% | -46.78% |
| 2018 | 11.30% | -20.95% |
| 2017 | 14.30% | -8.91% |
| 2016 | 15.70% | 65.54% |
Laurus Labs Limited (LAURUSLABS.BO) Average ROE
How has LAURUSLABS.BO ROE performed in the past?
The current ROE of Laurus Labs Limited (LAURUSLABS.BO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
10.50%
5-year avg
18.81%
10-year avg
15.58%
Laurus Labs Limited (LAURUSLABS.BO) ROE vs. Peers
How is LAURUSLABS.BO’s ROE compared to its peers?
Laurus Labs Limited’s ROE is less than Glenmark Pharmaceuticals Limited (8.72%), less than Glenmark Pharmaceuticals Limited (8.72%), less than Aurobindo Pharma Limited (10.43%), less than Biocon Limited (2.02%), less than Alkem Laboratories Limited (19.01%), less than Biocon Limited (2.02%), less than Alkem Laboratories Limited (19.01%), less than GlaxoSmithKline Pharmaceuticals Limited (52.46%), less than Aurobindo Pharma Limited (10.43%), less than GlaxoSmithKline Pharmaceuticals Limited (52.46%),
| Company | ROE | Market cap |
|---|---|---|
| 8.72% | $555.43B | |
| 8.72% | $554.74B | |
| 10.43% | $707.18B | |
| 2.02% | $524.42B | |
| 19.01% | $678.59B | |
| 2.02% | $524.22B | |
| 19.01% | $680.24B | |
| 52.46% | $430.81B | |
| 10.43% | $707.10B | |
| 52.46% | $431.24B |
Build a custom stock screener for Laurus Labs Limited (LAURUSLABS.BO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Laurus Labs Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Laurus Labs Limited (LAURUSLABS.BO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Laurus Labs Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Laurus Labs Limited's ROE?
How is the ROE calculated for Laurus Labs Limited (LAURUSLABS.BO)?
What is the highest ROE for Laurus Labs Limited (LAURUSLABS.BO)?
What is the 3-year average ROE for Laurus Labs Limited (LAURUSLABS.BO)?
What is the 5-year average ROE for Laurus Labs Limited (LAURUSLABS.BO)?
How does the current ROE for Laurus Labs Limited (LAURUSLABS.BO) compare to its historical average?